GALENA BIOPHARMA INC COM
RXII
RXII was delisted on the 25th of October, 2011.
88 hedge funds and large institutions have $84.9M invested in GALENA BIOPHARMA INC COM in 2014 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 37 increasing their positions, 15 reducing their positions, and 12 closing their positions.
147% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 15
100% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 12
35% more call options, than puts
Call options by funds: $15M | Put options by funds: $11.1M
16% more funds holding
Funds holding: 76 → 88 (+12)
32% less capital invested
Capital invested by funds: $124M → $84.9M (-$39.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
+$6.15M |
| 2 |
State Street
Boston,
Massachusetts
|
+$5.48M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.77M |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$1.36M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$1.24M |
| 2 |
Two Sigma Investments
New York
|
-$1.06M |
| 3 |
U
UBS
Zurich,
Switzerland
|
-$972K |
| 4 |
D.E. Shaw & Co
New York
|
-$396K |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$280K |
RXII Hedge Fund Activity: Q1 2014 in Review
88 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in GALENA BIOPHARMA INC COM (RXII) for Q1 2014, worth a combined $84.9M — down 32% from $124M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new RXII positions and 12 closed out — a net gain of 12 holders — while 37 added to existing stakes and 15 trimmed.
The largest buyer was Consonance Capital Management, adding an estimated $6.15M. The largest seller was EAM Investors, exiting entirely with an estimated $1.24M sold.
- 88 institutional investors held GALENA BIOPHARMA INC COM (RXII) as of Q1 2014, up from 76 in Q4 2013.
- Funds reported $84.9M of GALENA BIOPHARMA INC COM stock for Q1 2014, down 32% quarter-over-quarter.
- 24 funds opened new GALENA BIOPHARMA INC COM positions in Q1 2014 and 12 closed out, a net change of +12 holders.
- The largest GALENA BIOPHARMA INC COM buyer in Q1 2014 was Consonance Capital Management, an estimated $6.15M added.
- The largest GALENA BIOPHARMA INC COM seller in Q1 2014 was EAM Investors, an estimated $1.24M sold.
Based on aggregated 13F filings for Q1 2014.